Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /admin/ Disallow: /manager/ Disallow: /tempPickup/ Disallow: /tempUpload/ Sitemap: |
Title | Diamyd Medical - Developing precision therapies for type 1 |
Description | the Phase 3 trial Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. The share is listed on Nasdaq Stockholm First North (ticker: DMYD |
Keywords | Diabetes, Diabetes Type 1, Diabetes treatment, Diabetes research, Diamyd® |
WebSite | diamyd.com |
Host IP | 185.133.206.132 |
Location | - |
Site | Rank |
US$2,165,182
Last updated: 2023-05-10 06:30:47
diamyd.com has Semrush global rank of 4,888,413. diamyd.com has an estimated worth of US$ 2,165,182, based on its estimated Ads revenue. diamyd.com receives approximately 249,829 unique visitors each day. Its web server is located in -, with IP address 185.133.206.132. According to SiteAdvisor, diamyd.com is safe to visit. |
Purchase/Sale Value | US$2,165,182 |
Daily Ads Revenue | US$1,999 |
Monthly Ads Revenue | US$59,959 |
Yearly Ads Revenue | US$719,507 |
Daily Unique Visitors | 16,656 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
diamyd.com. | A | 1798 | IP: 185.133.206.132 |
diamyd.com. | AAAA | 1798 | IPV6: 2a01:a560:1::38 |
diamyd.com. | NS | 1800 | NS Record: ns1.beebyte.net. |
diamyd.com. | NS | 1800 | NS Record: ns3.beebyte.net. |
diamyd.com. | NS | 1800 | NS Record: ns2.beebyte.net. |
diamyd.com. | MX | 1800 | MX Record: 0 diamyd-com.mail.protection.outlook.com. |
diamyd.com. | TXT | 1800 | TXT Record: MS=ms38935596 |
diamyd.com. | TXT | 1800 | TXT Record: v=spf1 include:_spf.beebyte.se include:mailout.foretag.bahnhof.se include:spf.protection.outlook.com -all |
diamyd.com. | TXT | 1800 | TXT Record: google-site-verification=pnA4g5Voqa5HEtegsQglWxlF0wLaWJtp61nFFFvt5Tg |
SWE Toggle navigation English Svenska About Us The Company Board & Management Scientific Advisory Board Scientific Publications Events & Mediawatch Contact Us Diabetes Products Clinical Trials Investors Investor Relations CEO Comments Corporate Governance Press Releases Financial Reports Financial Calendar the Phase 3 trial DIAGNODE-3 and other ongoing trials Read More Developing precision therapies for type 1 diabetes VIDEO Intralymphatic immunotherapy with Diamyd ® VIDEO Available positions at Diamyd Medical We welcome candidates with relevant experience to join our entrepreneurial and collaborative team. Available Positions Press Releases April 20, 2023 Minor timeline revision for Remygen ® trial topline results Events & Mediawatch May 8, 2023 USA Video presentation from LSX World Congress Financial Reports April 5, 2023 Quarterly Report II 22/23 Company Presentation April 13, 2023 Download PDF --> Thanks to JDRF’s very large network, strong brand and financial support, the |
HTTP/1.1 301 Moved Permanently Content-Length: 146 Content-Type: text/html; charset=UTF-8 Location: https://www.diamyd.com/ Vary: Accept-Encoding X-Powered-By-Plesk: PleskWin Strict-Transport-Security: max-age=15768000; includeSubDomains Date: Tue, 02 Nov 2021 07:30:28 GMT HTTP/2 200 cache-control: private content-length: 68072 content-type: text/html; charset=utf-8 vary: Accept-Encoding x-powered-by-plesk: PleskWin strict-transport-security: max-age=15768000; includeSubDomains date: Tue, 02 Nov 2021 07:30:29 GMT |
Domain Name: DIAMYD.COM Registry Domain ID: 935346_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2020-03-25T04:39:46Z Creation Date: 1998-03-03T05:00:00Z Registry Expiry Date: 2022-03-02T05:00:00Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.BEEBYTE.NET Name Server: NS2.BEEBYTE.NET Name Server: NS3.BEEBYTE.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T15:40:51Z <<< |